Hindman Andrew A. 4
4 · Theravance Biopharma, Inc. · Filed Aug 24, 2020
Insider Transaction Report
Form 4
Hindman Andrew A.
SVP, Chief Financial Officer
Transactions
- Tax Payment
Ordinary Shares
2020-08-20$18.22/sh−4,323$78,765→ 123,135 total
4 · Theravance Biopharma, Inc. · Filed Aug 24, 2020
Ordinary Shares